London-based Purespring raised €95M in a Series B funding round led by Sofinnova Partners to initiate a Phase I/II clinical trial for IgAN.
Amount Raised
€95 Million
Round Type
Series B
LondonBiotechnologyInvestors
Description
Purespring has secured £80M (approx €95M) in an oversubscribed Series B funding round. The funding will support its pipeline, including initiating a clinical trial for a chronic kidney disease.
Quick answer
Purespring Therapeutics raised €95 Million in a Series B round, dated October 12, 2024. Investors: Syncona Limited, British Patient Capital, Forbion, Gilde Healthcare and Sofinnova Partners. Purespring Therapeutics is based in London, England, United Kingdom.
- How much did Purespring Therapeutics raise?
- Purespring Therapeutics raised €95 Million in a Series B round on October 12, 2024.
- Who invested in Purespring Therapeutics?
- Syncona Limited, British Patient Capital, Forbion, Gilde Healthcare and Sofinnova Partners are named as investors in this round.
- What does Purespring Therapeutics do?
- Purespring, which launched in November 2020 with £45 million of funding from Syncona Ltd, is the first company to be directly targeting the podocyte, a specialized kidney cell implicated in many kidney diseases, through..
- Where is Purespring Therapeutics based and how big is it?
- Purespring Therapeutics is based in London, England, United Kingdom.
- Who are the decision-makers at Purespring Therapeutics?
- Fundz holds 1 contact at Purespring Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Purespring Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Cradle raised $73M (Series B) on November 26, 2024.
- Memgen, Inc. raised $950K on November 26, 2024.
- Amplified Sciences raised $2.6M (Seed) on November 26, 2024.
- Exciting Instruments raised $5.1M (Seed) on November 26, 2024.
- Spinnaker Biosciences raised $667K (Seed) on November 26, 2024.
- Planet A Foods raised $30M on November 26, 2024.
Who to call at Purespring Therapeutics, and when
A new round usually means Purespring Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Purespring Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Purespring Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Purespring Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Purespring Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansPurespring Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.